{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:11:28Z","timestamp":1763766688278,"version":"3.45.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T00:00:00Z","timestamp":1763078400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,11,14]]},"abstract":"<jats:p>This study was aimed to evaluate the frequency of false-positive and false-negative results in multiparametric prostate magnetic resonance imaging (mpMRI), to investigate the potential contributing factors, and to analyze the clinical variables that may affect the diagnostic accuracy of mpMRI. This retrospective study included 1269 patients who underwent mpMRI between 2018 and 2024, followed by prostate biopsy within 3 months. Patients with Prostate Imaging-Reporting and Data System (PI-RADS) 1 to 3 lesions but positive biopsy results were classified as \u201cfalse-negative,\u201d whereas those with PI-RADS 4 to 5 lesions and negative biopsy results were considered \u201cfalse-positive.\u201d mpMRI findings were compared with clinical parameters such as prostate-specific antigen (PSA), PSA density, and age. Intra-observer consistency was assessed using a 2nd mpMRI reading performed by the same experienced radiologist. mpMRI may yield false results, particularly in cases involving anterior\/apical lesions or suboptimal image quality. Although the number of false-negative cases was low (n\u2005=\u200521), the possibility of missing clinically significant prostate cancers (ISUP Grade Group\u2005\u2265\u20052, Gleason\u2005\u2265\u20053\u2005+\u20054) remains an important concern due to the potential for delayed diagnosis and management. reevaluation by experienced radiologists significantly may enhance diagnostic precision. Incorporating PSA density and standardized imaging quality criteria into routine practice may improve the overall diagnostic performance of mpMRI. A total of 203 patients (15.99%) were identified as having discordant results: 1.65% (n\u2005=\u200521) were false-negatives, and 14.34% (n\u2005=\u2005182) were false-positives. Among the 182 index false-positive cases (defined as PI-RADS 4\u20135 with a negative biopsy within 3 months), 78 patients had visible lesions on mpMRI. During limited follow-up, 7 of these were later diagnosed with prostate cancer on repeat biopsy, including 4 with clinically significant disease. As repeat biopsies were not routinely performed, the number of false-positive cases at index evaluation remained 182. PSA density, advanced age, and lesion location (particularly the anterior and apical zones) were identified as potential contributors to false results. Intra-observer agreement for mpMRI interpretation was low, with a Cohen kappa coefficient of 0.099, indicating significant discordance.<\/jats:p>","DOI":"10.1097\/md.0000000000045969","type":"journal-article","created":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T21:02:18Z","timestamp":1763154138000},"page":"e45969","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic discordances in multiparametric prostate magnetic resonance imaging: A retrospective analysis of PI-RADS Scores and follow-up imaging"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6845-5496","authenticated-orcid":false,"given":"Rabia Mihriban","family":"K\u0131l\u0131n\u00e7","sequence":"first","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7170-0938","authenticated-orcid":false,"given":"Ba\u015fak","family":"Akbay","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faruk","family":"Bulut","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, Mugla Sitki Kocman University, Mugla, Turkey."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20251121","doi-asserted-by":"crossref","first-page":"111227","DOI":"10.1016\/j.ejrad.2023.111227","article-title":"Risk factors for prostate cancer in men with false-negative mpMRI: a retrospective single center cohort study of image quality scores and clinical parameters.","volume":"170","author":"Pausch","year":"2024","journal-title":"Eur J Radiol"},{"key":"R2-20251121","doi-asserted-by":"crossref","first-page":"e240019","DOI":"10.1148\/rycan.240019","article-title":"Clinical and imaging predictors of false-positive and false-negative results in prostate multiparametric MRI using PI-RADS version 2.","volume":"7","author":"Salka","year":"2025","journal-title":"Radiol Imag Cancer"},{"key":"R3-20251121","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging-Reporting and Data System Version 2.","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"R4-20251121","doi-asserted-by":"crossref","first-page":"28.e21","DOI":"10.1016\/j.urolonc.2023.11.004","article-title":"Clinical significance of prostate cancer identified by transperineal standard template biopsy in men with nonsuspicious multiparametric magnetic resonance imaging.","volume":"42","author":"Dahl","year":"2024","journal-title":"Urol Oncol"},{"key":"R5-20251121","doi-asserted-by":"crossref","first-page":"20211372","DOI":"10.1259\/bjr.20211372","article-title":"Prostate MRI quality: clinical impact of the PI-QUAL score in prostate cancer diagnostic work-up.","volume":"95","author":"Karanasios","year":"2022","journal-title":"Br J Radiol"},{"key":"R6-20251121","doi-asserted-by":"crossref","first-page":"110849","DOI":"10.1016\/j.ejrad.2023.110849","article-title":"Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy.","volume":"164","author":"Brembilla","year":"2023","journal-title":"Eur J Radiol"},{"key":"R7-20251121","first-page":"186","article-title":"Pathological outcomes following mpMRI and MRI-targeted biopsy in men with suspected prostate cancer.","volume":"64","author":"Stamatakis","year":"2013","journal-title":"Eur Urol"},{"key":"R8-20251121","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiol.2016152542","article-title":"Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists.","volume":"280","author":"Rosenkrantz","year":"2016","journal-title":"Radiology"},{"key":"R9-20251121","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00330-011-2377-y","article-title":"ESUR prostate MR guidelines 2012.","volume":"22","author":"Barentsz","year":"2012","journal-title":"Eur Radiol"},{"key":"R10-20251121","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.euo.2020.06.007","article-title":"Prostate imaging quality (PI-QUAL): a new quality control scoring system for multiparametric magnetic resonance imaging of the prostate from the PRECISION trial.","volume":"3","author":"Giganti","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"R11-20251121","first-page":"109880","article-title":"Prostate imaging quality and PI-QUAL score: impact on diagnostic accuracy and inter-reader agreement.","volume":"142","author":"P\u00e9rez","year":"2021","journal-title":"Eur J Radiol"},{"key":"R12-20251121","first-page":"410","article-title":"Detection of clinically significant prostate cancer: incremental value of diffusion-weighted imaging in biparametric MRI protocol with targeted and systematic biopsies.","volume":"295","author":"Stanzione","year":"2020","journal-title":"Radiology"},{"key":"R13-20251121","first-page":"1866","article-title":"Use of prostate MRI to improve biopsy decision-making and detect clinically significant cancer: results from the PRECISION trial.","volume":"380","author":"Rouvi\u00e8re","year":"2019","journal-title":"N Engl J Med"},{"key":"R14-20251121","first-page":"599","article-title":"Prostate cancer detection after negative MRI-targeted biopsy: implications for repeat biopsy and surveillance.","volume":"7","author":"Bertolo","year":"2021","journal-title":"Eur Urol Focus"},{"key":"R15-20251121","first-page":"266","article-title":"Usefulness of PSA density in predicting prostate cancer in patients with negative MRI findings and initial negative biopsy.","volume":"125","author":"Washino","year":"2020","journal-title":"BJU Int"},{"key":"R16-20251121","first-page":"821","article-title":"Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.","volume":"173","author":"Epstein","year":"2005","journal-title":"J Urol"},{"key":"R17-20251121","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/PAS.0000000000002376","article-title":"Atypical intraductal proliferation in prostate needle core biopsy: validation as a marker of unsampled adverse pathology in a clinicopathologic series of 142 new patients.","volume":"49","author":"Bahattarai","year":"2025","journal-title":"Am J Surg Pathol"},{"key":"R18-20251121","first-page":"129","article-title":"Chronic prostatitis: MRI findings and pitfalls.","volume":"208","author":"Hosseiny","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"R19-20251121","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/cancers17010053","article-title":"Analysis of inflammatory features in suspicious lesions for significant prostate cancer on magnetic resonance imaging \u2013 are they mimickers of prostate cancer?","volume":"17","author":"Morote","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R20-20251121","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.2214\/AJR.20.22843","article-title":"Prostatitis, the great mimicker of prostate cancer: can we differentiate them quantitatively with multiparametric MRI?","volume":"215","author":"Uysal","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"R21-20251121","first-page":"321","article-title":"Diagnostic performance of multiparametric MR imaging at 3.0 Tesla in discriminating prostate cancer from prostatitis: a histopathologic correlation.","volume":"52","author":"Aydin","year":"2020","journal-title":"East Anatolian J Med (EAJM)"},{"key":"R22-20251121","first-page":"20190181","article-title":"Multiparametric 3 Tesla MRI of the prostate: diagnostic performance and comparison of techniques.","volume":"92","author":"Baroni","year":"2019","journal-title":"Br J Radiol"},{"key":"R23-20251121","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","article-title":"Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.","volume":"389","author":"Ahmed","year":"2017","journal-title":"The Lancet"},{"key":"R24-20251121","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/bju.13427","article-title":"Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results.","volume":"118","author":"Wysock","year":"2016","journal-title":"BJU Int"},{"key":"R25-20251121","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.euo.2023.08.002","article-title":"Diagnostic performance of prostate-specific antigen density for detecting clinically significant prostate cancer in the era of magnetic resonance imaging: a systematic review and meta-analysis.","volume":"7","author":"Wang","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"R26-20251121","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1007\/s00330-019-06654-2","article-title":"Interreader variability in prostate mri reporting using prostate imaging reporting and data system version 2.1.","volume":"30","author":"Brembilla","year":"2020","journal-title":"Eur Radiol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:02:14Z","timestamp":1763766134000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000045969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,14]]},"references-count":26,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000045969","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,11,14]]},"assertion":[{"value":"2025-08-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}